INT MEDICAL (01501) has announced that all conditions under the placement agreement have been fulfilled, with the settlement completed on January 22, 2026, in accordance with the agreement's terms and conditions. Pursuant to the terms of the placement agreement, the placing agent has successfully placed a total of 35.2 million shares to no fewer than six placees at the placing price of HK$26.00 per share. This represents approximately 33.78% of the existing issued H-share capital immediately prior to the settlement, and 20.00% of the total existing issued share capital. Following the settlement as of the date of this announcement, the placed shares account for approximately 25.25% of the issued H-share capital and about 16.67% of the total issued share capital. The gross proceeds and net proceeds from the placement are approximately HK$915 million and HK$884 million, respectively, equivalent to a net issue price of HK$25.12 per share.